The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 22nd Feb 2013 07:12

Antofagasta: RBC upgrades from underperform to outperform.Ashmore Group: Citigroup raises target price from 330p to 355p upgrading to neutral. JP Morgan ups target price from 361p to 413p and maintains a neutral rating.Babcock International: Citigroup revises target price from 965p to 1185p and keeps its buy recommendation.BAE Systems: Deutsche Bank takes target price from 360p to 375p maintaining a buy recommendation. JP Morgan increases target price from 330p to 360p and retains a neutral rating.Barclays: Investec shifts target price from 340p to 345p and upgrades from hold to buy.BP: Canaccord Genuity downgrades from buy to hold with a target price of 500p.Bumi: JP Morgan reiterates underweight. Liberum reinitiates coverage at buy.British Sky Broadcasting: HSBC ups target price from 520p to 600p keeping an underweight rating.Capita Group: Citigroup moves target price from 870p to 990p, while leaving its buy recommendation unchanged.Chariot Oil & Gas: Jefferies ups target price from 36p to 50p and upgrades from hold to buy. Merchant Securities cuts target price from 29.20p to 20.60p, while reiterating a hold recommendation.CSR: UBS raises target price from 330p to 450p, while retaining a neutral rating. Deutsche Bank revises target price from 255p to 300p, while staying with its sell recommendation. JP Morgan takes target price from 450p to 475p and reiterates an overweight rating. Canaccord Genuity moves target price from 370p to 475p and keeps a buy recommendation.Drax Group: Goldman Sachs downgrades from buy to neutral.Filtrona: UBS increases target price from 600p to 660p and keeps a buy recommendation.Fresnillo: Societe Generale initiates with a target price of 1200p and a sell recommendation.GlaxoSmithKline: Jefferies moves target price from 1500p to 1550p and maintains a hold recommendation.Go-Ahead Group: HSBC revises target price from 1415p to 1485p, while staying with an overweight rating.G4S: HSBC shifts target price from 260p to 270p and downgrades to underweight.Halfords Group: UBS lowers target price from 290p to 280p and retains a sell recommendation.HSBC Holdings: Credit Suisse moves target price from 750p to 760p and keeps an outperform rating.Informa: Deutsche Bank shifts target price from 600p to 620p and leaves its buy recommendation unaltered. Citigroup takes target price from 520p to 550p reiterating a buy rating. Westhouse Securities ups target price from 493p to 525p and upgrades from neutral to add. Canaccord Genuity raises target price from 500p to 560p maintaining its buy recommendation. Investec increases target price from 495p to 520p keeping a hold recommendation.InterContinental Hotels Group: Citigroup increases target price from 1900p to 2200p retaining its buy recommendation.Interserve: Westhouse Securities raises target price from 432p to 537p, while downgrading from buy to add.Johnson Matthey: Morgan Stanley reduces target price form 2300p to 2200p retaining an underweight rating.Kingfisher: HSBC cuts target price from 340p to 335p and keeps its overweight rating.Lancashire: Nomura increases target price from 826p to 906p not altering its neutral rating.Millennium & Copthome: Credit Suisse moves target price from 524p to 542p and retains its neutral rating.Mondi: UBS ups target price from 720p to 840p, while leaving its neutral rating unchanged.Netplay: Merchant Securities initiates with a target price of 20p and a buy recommendation.New World Resources: JP Morgan shifts target price from 150p to 160p leaving its underweight rating unaltered.Old Mutual: JP Morgan raises target price from 186p to 209p, while downgrading to neutral.Pendragon: Panmure Gordon shifts target price from 15p to 19p and still recommends selling.Restaurant Group: Citigroup revises target price from 400p to 450p, while the buy recommendation is kept.REXAM: Credit Suisse shifts target price from 545p to 555p and stays with its neutral rating. Oriel Securities ups target prcie from 540p to 570p maintaining a buy recommendation.Sainsbury: Citigroup raises target price from 315p to 385p upgrading to buy.Serco Group: Citigroup shifts target price from 670p to 680p reiterating a buy recommendation.Shire: Morgan Stanley moves target price from 2350p to 2400p keeping an overweight rating.Spectris: N+1 Singer takes target price from 2135p to 2415p, while reiterating a hold recommendation. Investec ups target price from 2400p to 2575p and stays with its hold rating.Sports Direct International: Citigroup increases target price from 470p to 530p and still recommends buying.Whitbread: Citigroup raises target price from 2400p to 2675p and leaves its neutral rating unchanged. JP Morgan revises target price from 2650p to 2700p maintaining an overweight rating. Panmure Gordon ups target price from 1994p to 2500p, while reiterating a hold recommendation.William Hill: Jefferies raises target price from 370p to 500p keeping a buy recommendation.Xaar: Investec starts with a target price of 350p and a buy recommendation.
More News
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.